Scrub Typhus (Orientia tsutsugamushi)

Published on 22/03/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1441 times

Chapter 221 Scrub Typhus (Orientia tsutsugamushi)

Scrub typhus is an important cause of acute febrile illness in South and East Asia and the Pacific. Recent reports suggest the emergence of doxycycline-resistant strains. Concurrent scrub typhus can inhibit the replication of HIV virus.

Etiology

The causative agent of scrub typhus, or tsutsugamushi fever, is Orientia tsutsugamushi, which is distinct from other spotted fever and typhus group rickettsiae (see Table 220-1). O. tsutsugamushi lacks both lipopolysaccharide and peptidoglycan in its cell wall. Like other vasculotropic rickettsiae, O. tsutsugamushi infects endothelial cells and causes vasculitis, the predominant clinicopathologic feature of the disease. However, the organism also infects cardiac myocytes and macrophages.

Treatment and Supportive Care

The recommended treatment regimen for scrub typhus is doxycycline (4 mg/kg/day PO or IV divided every 12 hr, maximum 200 mg/day). Alternative regimens include tetracycline (25-50 mg/kg/day PO divided every 6 hr, maximum 2 g/day) or chloramphenicol (50-100 mg/kg/day divided every 6 hr IV, maximum 4 g/24 hr). If used, chloramphenicol should be monitored to maintain serum concentrations of 10-30 µg/mL. Therapy should be continued for a minimum of 5 days and until the patient has been afebrile for ≥3 days to avoid relapse. However, a single dose of oral doxycycline was reported effective for all 38 children treated with this regimen in a large series of children with scrub typhus from Thailand. Most children respond rapidly to doxycycline or chloramphenicol within 1-2 days (range, 1-5 days). Highly virulent or potentially doxycycline-resistant O. tsutsugamushi strains have emerged in some regions of Thailand. Clinical trials showed that azithromycin may be as effective and that rifampicin is superior to doxycycline in such cases. Likewise, a retrospective analysis in Korean children with scrub typhus showed that roxithromycin was as effective as either doxycycline or chloramphenicol, suggesting a role as an alternative therapy for children or pregnant women. The use of ciprofloxacin in pregnant women resulted in an adverse outcome in 5 of 5 pregnancies among Indian women. Intensive care may be required for hemodynamic management of severely affected patients.